291 studies found for:    "primary pulmonary hypertension"
Show Display Options
Rank Status Study
1 Recruiting Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Primary Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Familial Primary Pulmonary Hypertension
Interventions: Drug: Diltiazem Hydrochloride;   Drug: Sugar Pill
2 Withdrawn Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Conditions: Primary Myelofibrosis;   Primary Pulmonary Hypertension;   Secondary Myelofibrosis;   Pulmonary Arterial Hypertension
Intervention:
3 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Other: No specific intervention
4 Completed Imatinib (QTI571) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: QTI571;   Drug: Placebo
5 Completed Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension;   Ayerza Syndrome;   Pulmonary Hypertension
Intervention: Drug: Iloprost or placebo
6 Recruiting Coenzyme Q-10 and Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Nutritional Supplement Coenzyme Q-10
7 Recruiting Pharmacogenomics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension;   PAH WHO Group I
Interventions: Drug: Sitaxsentan;   Drug: Bosentan, Ambrisentan
8 Recruiting Auto-immunity and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   HIV Infection;   Congenital Heart Defect;   Systemic Sclerosis;   Connective Tissue Disease
Interventions: Procedure: skin biopsy;   Other: Blood Sample
9 Completed Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil;   Drug: Sugar Pill
10 Unknown  Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Fluoxetine
11 Completed The Early Recognition of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Device: ETED, CPET, RHC
12 Not yet recruiting Patient Reported Outcomes in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Other: Interview;   Other: Questionnaire
13 Recruiting Endothelial Function in Patients With Pulmonary Arterial Hypertension
Conditions: Hypertension, Pulmonary;   Pulmonary Arterial Hypertension;   Functional Disorder;   Genetics
Interventions: Device: EndoPAT measurement;   Biological: Blood Test
14 Withdrawn Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Iloprost Inhalation Solution (Ventavis)
15 Recruiting Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Submaximal exercises
16 Enrolling by invitation ACT-293987 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: ACT-293987
17 Not yet recruiting Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
Conditions: Muscle Weakness;   Pulmonary Arterial Hypertension
Intervention:
18 Completed
Has Results
Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: iloprost (5 µg);   Drug: placebo
19 Active, not recruiting Pulmonary Arterial Hypertension in Children
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: bosentan
20 Recruiting Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab;   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years